ERP Failure Slashes Margin to 6.4%
DistributionNow's (DNOW) merger with MRC Global is off to a rocky start, with a flawed Oracle ERP implementation gutting profitability and raising questions about the deal's value. While fourth-quarter 2025 revenue reached $959 million, boosted by $388 million from the newly acquired MRC assets, the underlying financial health deteriorated sharply. The company's adjusted EBITDA margin compressed to just 6.4%, a significant drop from the 8.2% legacy DNOW reported for the full year.
The source of the trouble is an ERP system integration that CEO David Cherechinsky admitted is a "much heavier lift than previously known." This disruption is actively hampering core processes across an estimated 40% of the combined U.S. business, leading to what the company termed "continuing negative operating and financial impacts." The inability to smoothly integrate systems has immediately undermined the financial rationale for the merger.
Investors Flee as Stock Drops 15.5% in 2026
The market has responded decisively to the operational turmoil, sending DNOW's stock down 15.47% year-to-date in 2026. The company's refusal to issue formal 2026 guidance has amplified investor uncertainty, leaving the market to price in further execution risks. The stock now trades at $11.20, significantly below the analyst consensus target of $16.
Institutional investors are voting with their feet. On February 17, 2026, a regulatory filing revealed that Quantedge Capital had completely liquidated its position, selling 351,310 shares previously valued at $5.36 million. This exit from a key fund underscores growing skepticism that DNOW can deliver on its post-merger promises in the near term.
$70M Synergy Goal Hinges on Integration Fix
DNOW's strategic bet is that acquiring MRC Global will create a more diversified industrial distributor capable of generating $70 million in cost synergies over three years. However, these long-term benefits are entirely contingent on resolving the immediate ERP crisis. Management must stabilize operations within the next two quarters to prevent further margin erosion and revenue loss.
The company's struggles stand in stark contrast to competitor Fastenal, which is achieving 11% year-over-year revenue growth organically through technology penetration rather than high-risk acquisitions. While DNOW is betting on scale, its path forward is now defined by a race to fix its internal systems before market conditions or investor patience runs out.
